1.
Validation of ICD-9-CM codes for identification of acetaminophen-related emergency department visits in a large pediatric hospital
Sofia
de Achaval,
Chris
Feudtner,
Shana
Palla,
Maria
E
Suarez-Almazor
BMC Health Services Research 2013, 13 :72 (21 February 2013)
Abstract | Full text | PDF | PubMed
2.
Validation of the M. D. Anderson symptom inventory multiple myeloma module
Desiree
Jones,
Elisabeth
G
Vichaya,
Xin Shelley
Wang,
Loretta
A
Williams,
Nina
D
Shah,
Sheeba
K
Thomas,
Valen
E
Johnson,
Richard
E
Champlin,
Charles
S
Cleeland,
Tito
R
Mendoza
Journal of Hematology & Oncology 2013, 6 :13 (5 February 2013)
Abstract | Provisional PDF
| PubMed
3.
Standardized treatment planning methodology for passively scattered proton craniospinal irradiation
Annelise
Giebeler,
Wayne
D
Newhauser,
Richard
A
Amos,
Anita
Mahajan,
Kenneth
Homann,
Rebecca
M
Howell
Radiation Oncology 2013, 8 :32 (3 February 2013)
Abstract | Provisional PDF
| PubMed
4.
Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century
Adam
S
Garden,
Merrill
S
Kies,
William
H
Morrison,
Randal
S
Weber,
Steven
J
Frank,
Bonnie
S
Glisson,
Gary
B
Gunn,
Beth
M
Beadle,
K Kian
Ang,
David
I
Rosenthal,
Erich
M
Sturgis
Radiation Oncology 2013, 8 :21 (29 January 2013)
Abstract | Full text | PDF | PubMed
5.
Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy
Heath
D
Skinner,
Eric
A
Strom,
Sabin
B
Motwani,
Wendy
A
Woodward,
Marjorie
C
Green,
Gildy
Babiera,
Daniel
J
Booser,
Funda
Meric-Bernstam,
Thomas
A
Buchholz
Radiation Oncology 2013, 8 :13 (11 January 2013)
Abstract | Full text | PDF | PubMed
6.
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
Wei-Lien
Wang,
Daniela
Katz,
Dejka
M
Araujo,
Vinod
Ravi,
Joseph
A
Ludwig,
Jonathan
C
Trent,
Shreyaskumar
R
Patel,
Patrick
P
Lin,
Ashleigh
Guadagnolo,
Dolores
Lòpez-Terrada,
Angelo
Paola
dei Tos,
Valerie
O
Lewis,
Dina
Lev,
Raphael
E
Pollock,
Gunar
K
Zagars,
Robert
S
Benjamin,
John
E
Madewell,
Alexander
J
Lazar
Clinical Sarcoma Research 2012, 2 :25 (29 December 2012)
Abstract | Provisional PDF
| PubMed
7.
The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model
Hui
Liu,
Yukinari
Kato,
Stephanie
A
Erzinger,
Galina
M
Kiriakova,
Yongzhen
Qian,
Diane
Palmieri,
Patricia
S
Steeg,
Janet
E
Price
BMC Cancer 2012, 12 :583 (7 December 2012)
Abstract | Full text | PDF | PubMed
8.
Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy
Musaffe
Tuna,
Zhenlin
Ju,
Christopher
I
Amos,
Gordon
B
Mills
BMC Medical Genomics 2012, 5 :60 (5 December 2012)
Abstract | Full text | PDF | PubMed
9.
Challenges of the information age: the impact of false discovery on pathway identification
Colin
J
Rog,
Srinivasa
C
Chekuri,
Mary
E
Edgerton
BMC Research Notes 2012, 5 :647 (21 November 2012)
Abstract | Full text | PDF | PubMed
10.
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
Funda
Meric-Bernstam,
Huiqin
Chen,
Argun
Akcakanat,
Kim-Anh
Do,
Ana
Lluch,
Bryan
T
Hennessy,
Gabriel
N
Hortobagyi,
Gordon
B
Mills,
Ana
Gonzalez-Angulo
Breast Cancer Research 2012, 14 :R138 (26 October 2012)
Abstract | Full text | PDF | PubMed
11.
An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays
Huifang
Guo,
Wenbin
Liu,
Zhenlin
Ju,
Pheroze
Tamboli,
Eric
Jonasch,
Gordon
B
Mills,
Yiling
Lu,
Bryan
T
Hennessy,
Dimitra
Tsavachidou
Proteome Science 2012, 10 :56 (24 September 2012)
Abstract | Full text | PDF | PubMed
12.
Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer
Colin
Brooks,
Tommy
Sheu,
Kathleen
Bridges,
Kathy
Mason,
Deborah
Kuban,
Paul
Mathew,
Raymond
Meyn
Radiation Oncology 2012, 7 :154 (11 September 2012)
Abstract | Full text | PDF | PubMed
13.
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
Joe
Y
Chang,
Hui
Liu,
Peter
Balter,
Ritsuko
Komaki,
Zhongxing
Liao,
James
Welsh,
Reza
J
Mehran,
Jack
A
Roth,
Stephen
G
Swisher
Radiation Oncology 2012, 7 :152 (10 September 2012)
Abstract | Full text | PDF | PubMed
14.
FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy
Zuo-Lin
Xiang,
Jeremy
Erasmus,
Ritsuko
Komaki,
James
D
Cox,
Joe
Y
Chang
Radiation Oncology 2012, 7 :144 (28 August 2012)
Abstract | Full text | PDF | PubMed
15.
The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells
Urszula
Daniluk,
Celine
Kerros,
Rong-Hua
Tao,
Jillian F
Wise,
Xue
Ao,
Zuzana
Berkova,
Felipe
Samaniego
Journal of Experimental & Clinical Cancer Research 2012, 31 :69 (28 August 2012)
Abstract | Full text | PDF | PubMed
16.
A randomized controlled trial to assess the efficacy of an interactive mobile messaging intervention for underserved smokers: Project ACTION
Damon
J
Vidrine,
Faith
E
Fletcher,
Heather
E
Danysh,
Salma
Marani,
Jennifer
Vidrine,
Scott
B
Cantor,
Alexander
V
Prokhorov
BMC Public Health 2012, 12 :696 (25 August 2012)
Abstract | Full text | PDF | PubMed
17.
Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols
Wesley
Greaves,
Lianchun
Xiao,
Beatriz
Sanchez-Espiridion,
Kranthi
Kunkalla,
Kunal
S
Dave,
Cynthia
S
Liang,
Rajesh
R
Singh,
Anas
Younes,
L
Medeiros,
Francisco
Vega
Journal of Hematology & Oncology 2012, 5 :47 (7 August 2012)
Abstract | Full text | PDF | PubMed
18.
Optimal experiment selection for parameter estimation in biological differential equation models
Mark
K
Transtrum,
Peng
Qiu
BMC Bioinformatics 2012, 13 :181 (27 July 2012)
Abstract | Full text | PDF | PubMed
19.
A novel SYBR-based duplex qPCR for the detection of gene dosage: detection of an APC large deletion in a familial adenomatous polyposis patient with an unusual phenotype
Giovana
Torrezan,
Felipe Cavalcanti
da Silva,
Ana Cristina
Krepischi,
Érika Maria
dos Santos,
Benedito
Rossi,
Dirce
Carraro
BMC Medical Genetics 2012, 13 :55 (16 July 2012)
Abstract | Full text | PDF | PubMed
20.
Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study
Huanlei
Wu,
Li
Xu,
Jigui
Chen,
Junbo
Hu,
Shiying
Yu,
Guangyuan
Hu,
Liu
Huang,
Xiaoping
Chen,
Xianglin
Yuan,
Guojun
Li
BMC Cancer 2012, 12 :276 (3 July 2012)
Abstract | Full text | PDF | PubMed
21.
Is a prostate cancer screening anxiety measure invariant across two different samples of age-appropriate men?
Suzanne
K
Linder,
Paul
R
Swank,
Sally
W
Vernon,
Robert
O
Morgan,
Patricia
D
Mullen,
Robert
J
Volk
BMC Medical Informatics and Decision Making 2012, 12 :52 (8 June 2012)
Abstract | Full text | PDF | PubMed
22.
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
Abigail
S
Caudle,
Tse-Kuan
Yu,
Susan
L
Tucker,
Isabelle
Bedrosian,
Jennifer
K
Litton,
Ana
M
Gonzalez-Angulo,
Karen
Hoffman,
Funda
Meric-Bernstam,
Kelly
K
Hunt,
Thomas
A
Buchholz,
Elizabeth
A
Mittendorf
Breast Cancer Research 2012, 14 :R83 (23 May 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
23.
Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy
Laura
S
Dominici,
Elizabeth
A
Mittendorf,
Xumei
Wang,
Jun
Liu,
Henry
M
Kuerer,
Kelly
K
Hunt,
Abenaa
Brewster,
Gildy
V
Babiera,
Thomas
A
Buchholz,
Funda
Meric-Bernstam,
Isabelle
Bedrosian
Breast Cancer Research 2012, 14 :R82 (23 May 2012)
Abstract | Full text | PDF | PubMed
24.
Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer
Susan
L
McGovern,
Yuan
Qi,
Lajos
Pusztai,
William
F
Symmans,
Thomas
A
Buchholz
Breast Cancer Research 2012, 14 :R72 (4 May 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
The essential centromere protein, CENP-A, is a strong prognostic marker for distant relapse in estrogen-receptor positive breast cancer not treated with systemic therapy, and may contribute to disease progression.
25.
Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck
Ziyuan
Zhou,
Erich
M
Sturgis,
Zhensheng
Liu,
Li-E
Wang,
Qingyi
Wei,
Guojun
Li
BMC Cancer 2012, 12 :159 (1 May 2012)
Abstract | Full text | PDF | PubMed